Coya Therapeutics, Inc. (COYA) stock
COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)
Close on Nov 17, 2026Market cap $70.84MP/E –Yield –
Coya Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Coya Therapeutics's price to book ratio was 1.7× on Nov 11, 2026, against 4.0× a year earlier. Over the last 4 years it ranged from 1.7× to 7.3×, with a median of 2.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | −1.8 |
| 2025 | Dec 31, 2025 | 3.6× | +0.8 |
| 2024 | Dec 31, 2024 | 2.7× | −4.6 |
| 2023 | Dec 29, 2023 | 7.3× | +3.9 |
| 2022 | Dec 30, 2022 | 3.4× | – |
See a number that looks wrong?